News

BioAgilytix has announced the acquisition of IPM Biotech, a German-based bioanalytical contract research laboratory renowned for its expertise in large molecule bioanalysis, particularly in the area of immunogenicity.

Researchers have resolved a mystery about how a promising new class of anti-cancer drugs, called nutlins, work - paving the way for improving the future of cancer treatment.

Compound prevents multidrug-resistant fungi from pumping out drugs.

Company has announced results from OPuS-2, a clinical trial of avoralstat for the prophylactic treatment of hereditary angioedema (HAE) attacks.

Company has announced manufacturing agreement for development of RT-100 Gene Therapy.

Company has announced research agreement with the UAB Comprehensive Cancer Center for study the effectiveness of traditional tissue biopsies compared to liquid biopsies in tumor detection and monitoring.

Company has announced receipt of a $2.5 million investment from the Gates Foundation for MAPS vaccine targeting Streptococcus pneumoniae (pneumococcus) towards clinical testing.

Findings may lead to better drug administration practices than current methods.

Here's one more benefit of exercise: mice who spent their free time on a running wheel were better able to shrink tumors (a 50% reduction in tumor size) compared to their less active counterparts.

Team uses chemical compound to restore affected brain regions; findings could lead to new treatment strategies.